Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.

Saved in:
Bibliographic Details
Title: Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
Authors: Rosenfeld WE; Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, Missouri, USA., Abou-Khalil B; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Aboumatar S; Austin Epilepsy Care Center, Austin, Texas, USA., Bhatia P; Neuro-Pain Medical Center, Fresno, California, USA., Biton V; Arkansas Epilepsy Program, Little Rock, Arkansas, USA., Krauss GL; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Sperling MR; Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Vossler DG; University of Washington School of Medicine, Seattle, Washington, USA., Klein P; Mid-Atlantic Epilepsy and Sleep Center, Bethesda, Maryland, USA., Wechsler R; Consultants in Epilepsy & Neurology, PLLC, Boise, Idaho, USA.; Idaho Comprehensive Epilepsy Center, Boise, Idaho, USA.
Source: Epilepsia [Epilepsia] 2021 Dec; Vol. 62 (12), pp. 3016-3028. Date of Electronic Publication: 2021 Oct 11.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1528-1167
DOI:10.1111/epi.17092